Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Anheuser-Busch InBev    ABI   BE0974293251

ANHEUSER-BUSCH INBEV

(ABI)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Anheuser Busch InBev : Biotech Firm Moves to Revive Hong Kong IPO Market--Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/11/2019 | 08:40pm EDT

By Joanne Chiu and Frances Yoon

A Chinese biotechnology company kicked off what would be Hong Kong's first sizable listing after a summer of unrest and stock-market weakness, on the same day the city's exchange-operator made a surprise bid for its London rival.

The listing by Shanghai Henlius Biotech Inc., which could raise up to $477 million, would reopen a market that has shrunk sharply compared with 2018, with a couple of blockbuster deals falling through. Trade tensions, China's economic slowdown and unrest in the city have dented market sentiment, and share-trading has declined year over year.

Companies raised $9.5 billion in IPOs this year through Sept. 11, roughly 40% of the total raised in the same period last year, according to Dealogic.

In July, Anheuser-Busch InBev SA halted a unit's nearly $10 billion IPO, blaming market conditions, and in August people familiar with the matter said Alibaba Group Holding Ltd. had postponed plans for a multibillion-dollar listing in the city.

Late Wednesday, AB InBev said it was resuming its application to list the Asian unit in Hong Kong, adding that any final decision about taking the business public would "depend on a number of factors and prevailing market conditions."

The Shanghai Henlius listing would represent about 12% of its enlarged share base, and value the company at about $3 billion to $3.5 billion, according to a term sheet seen by The Wall Street Journal. The figures don't include an overallotment option to sell more stock.

Other prospective issuers include consumer lender Home Credit NV, which is looking to raise up to $1.5 billion and list by early in the fourth quarter, and Chinese sportswear retailer Topsports International Holdings Ltd., which aims to raise about $1 billion.

Sungho Im, chief executive at asset-management firm IM Capital Partners Ltd., said investors' risk appetite is returning.

The city also is playing host to new bond sales. Volumes dipped to $5.9 billion in August, but were still higher than the same month a year earlier, and have since recovered to top $7 billion in the first 11 days of this month, Dealogic says.

The figures cover Hong Kong-listed deals in dollars, yen, or euros by bond issuers from Asian countries other than Japan.

Deals this week include $2.5 billion of green bonds from Industrial and Commercial Bank of China's Hong Kong branch, and a $600 million perpetual bond from Hong Kong insurer FWD Group. It priced the deal to yield 6.375%, lower than initial guidance for a yield of around 6.5%, implying solid demand.

In August, three Hong Kong-based bankers said investment roadshows had been put off until September, including one for a Chinese developer planning an inaugural dollar-bond sale. Some bankers have been forced to cancel trips to meet clients or met them in mainland China, while executives at some Chinese issuers also delayed trips.

Citigroup's Asia co-head of debt syndicate, Rishi Jalan, said bond deals this month had been oversubscribed. He said issuers had to pay little or even negative new-issue premiums to borrow, meaning some new securities offered lower yields than comparable existing debt. "Most investors in Hong Kong are international players who look at global rates and macroeconomic trends while making investment decisions," Jalan said. "The recent events in Hong Kong have not dampened investor sentiment in primary bond markets."

Write to Joanne Chiu at joanne.chiu@wsj.com and Frances Yoon at frances.yoon@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ANHEUSER-BUSCH INBEV
09/13ANHEUSER BUSCH INBEV : India police probing AB InBev in New Delhi tax evasion ca..
RE
09/12NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/12EUROPE : ECB stimulus draws tepid response from European stocks; banks end flat
RE
09/12NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/12NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/12EUROPE MARKETS: Europe Stocks Rise As ECB Cuts Rates, Launches Fresh Bond-buy..
DJ
09/12NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/12AB INBEV SET TO REVIVE BUDWEISER ASI : sources
RE
09/12AB InBev set to revive Budweiser Asia IPO with $5 billion float - sources
RE
09/12BUD LIGHT : Brewer Plans Slimmed-Down IPO in Hong Kong -- Update
DJ
More news
Financials (USD)
Sales 2019 55 295 M
EBIT 2019 18 461 M
Net income 2019 11 075 M
Debt 2019 96 504 M
Yield 2019 2,05%
P/E ratio 2019 17,9x
P/E ratio 2020 19,8x
EV / Sales2019 5,17x
EV / Sales2020 4,83x
Capitalization 189 B
Chart ANHEUSER-BUSCH INBEV
Duration : Period :
Anheuser-Busch InBev Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANHEUSER-BUSCH INBEV
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 33
Average target price 104,58  $
Last Close Price 96,53  $
Spread / Highest target 26,0%
Spread / Average Target 8,35%
Spread / Lowest Target -37,1%
EPS Revisions
Managers
NameTitle
Carlos Alves de Brito Chief Executive Officer
Olivier Goudet Chairman
Luis Felipe Pedreira Dutra Leite Chief Financial & Solutions Officer
Martin J. Barrington Non-Executive Director
William F. Gifford Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ANHEUSER-BUSCH INBEV51.11%189 190
AMBEV SA25.94%74 052
HEINEKEN25.67%61 261
ASAHI GROUP HOLDINGS LTD25.67%22 364
CARLSBERG A/S42.91%21 737
KIRIN HOLDINGS CO LTD-1.69%17 999